SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+9.9%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.89B
AUM Growth
+$159M
(+9.2%)
Cap. Flow
+$41.8M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
355
New
45
Increased
117
Reduced
138
Closed
28
Top Buys
| 1 |
Capital One
COF
|
$39.1M |
| 2 |
Envista
NVST
|
$25.6M |
| 3 |
West Pharmaceutical
WST
|
$24M |
| 4 |
JPMorgan Chase
JPM
|
$23.4M |
| 5 |
Eaton
ETN
|
$16.4M |
Top Sells
| 1 |
Allstate
ALL
|
$23.8M |
| 2 |
Apple
AAPL
|
$22.3M |
| 3 |
Cadence Design Systems
CDNS
|
$21.7M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$20.7M |
| 5 |
Zebra Technologies
ZBRA
|
$17.1M |
Sector Composition
| 1 | Technology | 30.41% |
| 2 | Consumer Discretionary | 14.8% |
| 3 | Healthcare | 14.63% |
| 4 | Financials | 11.82% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Federated Hermes
FHI
$4.1B
| $21K | ﹤0.01% |
660
-17,700
| -96% | -$563K |
|
202
Cassava Sciences
SAVA
$104M
| $21K | ﹤0.01% |
+460
| New | +$21K |
|
203
Sleep Number
SNBR
$220M
| $21K | ﹤0.01% |
145
-3,975
| -96% | -$576K |
|
|
BERY
204
DELISTED
Berry Global Group, Inc.
BERY
| $21K | ﹤0.01% |
370
+43
| +13% | +$2.44K |
|
|
ETRN
205
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $21K | ﹤0.01% |
2,631
+340
| +15% | +$2.71K |
|
206
Amneal Pharmaceuticals
AMRX
$3.02B
| $20K | ﹤0.01% |
2,990
-69,640
| -96% | -$466K |
|
207
Baker Hughes
BKR
$44.9B
| $20K | ﹤0.01% |
904
+120
| +15% | +$2.66K |
|
208
HF Sinclair
DINO
$9.56B
| $20K | ﹤0.01% |
558
+54
| +11% | +$1.94K |
|
|
SYNH
209
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $20K | ﹤0.01% |
270
-7,470
| -97% | -$553K |
|
210
American Express
AXP
$227B
| $19K | ﹤0.01% |
137
+23
| +20% | +$3.19K |
|
211
Ecopetrol
EC
$18.7B
| $19K | ﹤0.01% |
1,480
+190
| +15% | +$2.44K |
|
212
Extreme Networks
EXTR
$2.87B
| $19K | ﹤0.01% |
+2,130
| New | +$19K |
|
213
Goldman Sachs
GS
$223B
| $19K | ﹤0.01% |
57
+10
| +21% | +$3.33K |
|
214
Nasdaq
NDAQ
$53.6B
| $19K | ﹤0.01% |
378
+63
| +20% | +$3.17K |
|
|
PRSP
215
DELISTED
Perspecta Inc. Common Stock
PRSP
| $19K | ﹤0.01% |
670
-17,900
| -96% | -$508K |
|
216
Boot Barn
BOOT
$5.58B
| $18K | ﹤0.01% |
+290
| New | +$18K |
|
217
DuPont de Nemours
DD
$32.6B
| $18K | ﹤0.01% |
239
+38
| +19% | +$2.86K |
|
|
DFS
218
DELISTED
Discover Financial Services
DFS
| $18K | ﹤0.01% |
186
+27
| +17% | +$2.61K |
|
219
EQT Corp
EQT
$32.2B
| $18K | ﹤0.01% |
980
+90
| +10% | +$1.65K |
|
220
First American
FAF
$6.83B
| $18K | ﹤0.01% |
320
+50
| +19% | +$2.81K |
|
221
Huntsman Corp
HUN
$1.95B
| $18K | ﹤0.01% |
621
+70
| +13% | +$2.03K |
|
222
Jack in the Box
JACK
$386M
| $18K | ﹤0.01% |
160
-4,280
| -96% | -$482K |
|
223
Supernus Pharmaceuticals
SUPN
$2.58B
| $18K | ﹤0.01% |
700
-31,368
| -98% | -$807K |
|
224
Kinross Gold
KGC
$26.9B
| $17K | ﹤0.01% |
2,504
+290
| +13% | +$1.97K |
|
225
Enbridge
ENB
$105B
| $16K | ﹤0.01% |
453
+50
| +12% | +$1.77K |
|